In response to growing global demand, the Schott Group is to expand its production capacity for pharmaceutical glass.
The company plans to put a new melting tank for its Type I glass named Fiolax clear into operation at its site in Mitterteich, Germany.
From 2015 to 2016, it will invest a sum in the mid-double-digit millions in the expansion. The move will increase the company’s production capacity for glass tubing to more than 140,000 tons.
Fiolax glass tubing is used to manufacture vials, syringes, ampoules and cartridges. The pharmaceutical industry then fills these with injectable drugs. The needs of the pharmaceutical companies for such packaging are rising steadily because of increased regulatory pressure and stringent standards for patient safety.
Fiolax is designed to meet these requirements.
Thanks to its properties and its chemical resistance the drugs are kept stored in the best possible way.
Construction work on the new tank has already begun and will be completed in spring 2016. A new palletising line will complement the extension.
